Diagnostic Study of Patients With Stage I Testicular Cancer

Completed · Not applicable

Conditions studied: Testicular Germ Cell Tumor

In brief

RATIONALE: Diagnostic procedures may improve a doctor's ability to predict the recurrence of testicular cancer. PURPOSE: Diagnostic trial to detect the risk of recurrent disease in patients who have stage I testicular cancer and who have undergone orchiectomy within the previous 12 weeks.

Key facts

Study ID

NCT00003800

Run by

Eastern Cooperative Oncology Group

People needed

76

Starts

1999-11-16

Last updated by the study team

2023-06-22

Who can join

Age: 15 and older, up to 120. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Veterans Affairs Medical Center - Lakeside Chicago — Chicago, Illinois, United States
• Robert H. Lurie Comprehensive Cancer Center at Northwestern University — Chicago, Illinois, United States
• Indiana University Cancer Center — Indianapolis, Indiana, United States
• CCOP - Cedar Rapids Oncology Project — Cedar Rapids, Iowa, United States
• CCOP - Kalamazoo — Kalamazoo, Michigan, United States
• West Michigan Cancer Center — Kalamazoo, Michigan, United States
• CCOP - Southern Nevada Cancer Research Foundation — Las Vegas, Nevada, United States
• MetroHealth's Cancer Care Center at MetroHealth Medical Center — Cleveland, Ohio, United States
• CCOP - Columbus — Columbus, Ohio, United States
• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
• CCOP - Scott and White Hospital — Temple, Texas, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.